Skip to content

Clinical trials

Completed Phase 3 Lung Diseases, Obstructive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Obstructive Phase: Phase 3 Status: Completed Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20123
20132
20145
20153
20164
20172

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca15
National Heart, Lung, and Blood Institute (NHLBI)5
Novartis Pharmaceuticals2
Assistance Publique - Hôpitaux de Paris1
Cornell University1
Imperial College London1
Johns Hopkins Bloomberg School of Public Health1
McGill University1
University of Minnesota1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Obstructive28
Lung Diseases25
Respiratory Tract Diseases17
Asthma14
Bronchial Diseases14
Pulmonary Disease, Chronic Obstructive13
Emphysema2
Bronchiolitis1
Bronchiolitis, Viral1
Bronchitis, Chronic1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.